These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 13779077)
1. Chlorphenoxamine hydrochloride in parkinsonism. A controlled trial. ULDALL PR; WALTON JN; NEWELL DJ Br Med J; 1961 Jun; 1(5240):1649-52. PubMed ID: 13779077 [No Abstract] [Full Text] [Related]
2. Treatment of Parkinson's disease with chlorphenoxamine. MAGEE KR; CURRIER RD J Mich State Med Soc; 1960 Sep; 59():1364-5. PubMed ID: 13765186 [No Abstract] [Full Text] [Related]
3. Akineton in the treatment of parkinsonism. O'DOHERTY DS; EDWARDS CE Med Ann Dist Columbia; 1960 Jul; 29():378-80. PubMed ID: 14428055 [No Abstract] [Full Text] [Related]
4. Biperiden (Akineton) in Parkinsonism. TIMBERLAKE WH; SCHWAB RS; ENGLAND AC Arch Neurol; 1961 Nov; 5():560-4. PubMed ID: 13921278 [No Abstract] [Full Text] [Related]
5. A clinical assessment of orphenadrine (disipal) in the treatment of Parkinsonism. ROBINSON LR; DICK TH Ulster Med J; 1960 Jun; 29(1):64-9. PubMed ID: 14437972 [No Abstract] [Full Text] [Related]
6. [Experiences with a new substance for the suppression of Parkinson tremors]. SCHULZ HP Med Klin; 1961 Dec; 56():2174-6. PubMed ID: 13909545 [No Abstract] [Full Text] [Related]
7. Treatment of paralysis agitans with chlorphenoxamine hydrochloride. DOSHAY LJ; CONSTABLE K J Am Med Assoc; 1959 May; 170(1):37-41. PubMed ID: 13640980 [No Abstract] [Full Text] [Related]
8. [Disipal and the correction of parkinsonism induced by neuroleptics. (A critical review)]. MEURICE E Acta Neurol Psychiatr Belg; 1961 Jan; 61():47-66. PubMed ID: 13769933 [No Abstract] [Full Text] [Related]
9. [P 119, a spasmolytic for the treatment of parkinsonism]. VON KEYSERLINGK H Dtsch Gesundheitsw; 1955 Oct; 10(41):1338-9. PubMed ID: 13277399 [No Abstract] [Full Text] [Related]
10. The treatment of parkinsonism with a new antispasmodic compound. MAGEE KR; DEJONG RN Med Bull (Ann Arbor); 1953 Mar; 19(3):59-61. PubMed ID: 13049719 [No Abstract] [Full Text] [Related]
11. [Patent rights regarding a preparation for parkinsonism]. TEUNISSEN HP Pharm Weekbl; 1951 Sep; 86(39-40):705-10. PubMed ID: 14891366 [No Abstract] [Full Text] [Related]
12. [Old and new methods of therapy in parkinsonism following epidemic encephalitis]. TRIPI G Rass Studi Psichiatr; 1952; 41(5):1055-65. PubMed ID: 13014381 [No Abstract] [Full Text] [Related]
13. Benactyzine in patients with violent tempers and patients with Parkinsonism. NATHAN PW Br Med J; 1958 Apr; 1(5076):926-8. PubMed ID: 13523231 [No Abstract] [Full Text] [Related]
14. The acute and chronic toxicities of chlorphenoxamine. KERLEY TL; NEWBERNE JW; BRINKMAN DC; WEAVER LC Toxicol Appl Pharmacol; 1962 Sep; 4():638-49. PubMed ID: 14455272 [No Abstract] [Full Text] [Related]
16. Assessment of drug therapy in Parkinsonism. ONUAGULUCHI G Br Med J; 1963 Feb; 1(5328):443-8. PubMed ID: 13940177 [No Abstract] [Full Text] [Related]
17. [The present status of drug therapy of Parkinson's syndrome]. von MONAKOW K Praxis; 1962 Jan; 51():30-3. PubMed ID: 14475321 [No Abstract] [Full Text] [Related]
18. [Therapeutic experience with a new Hungarian drug parkazin in ambulatory practice]. KLIMES K Orv Hetil; 1961 Oct; 102():2046-8. PubMed ID: 14456960 [No Abstract] [Full Text] [Related]
19. [Preparations for the treatment of Parkinsonism-cyclodol and ridinol]. POLEZHAEVA AI Med Prom SSSR; 1962 Oct; 10():54-6. PubMed ID: 13944304 [No Abstract] [Full Text] [Related]
20. Procyclidine hydrochloride (kemadrin) treatment of parkinsonism; result in 108 patients. ZIER A; DOSHAY LJ Neurology; 1957 Jul; 7(7):485-9. PubMed ID: 13451881 [No Abstract] [Full Text] [Related] [Next] [New Search]